Great conversation on "Why did I get Colitis/Crohn's?"
IBD Drive Time: Peter Higgins, MD, on the Etiology of Inflammatory Bowel Disease
@ibddoctor
@MLongMD
@Marylandibddoc
Blood assay / liquid biopsy for lymph node metastasis of T1 colon cancer found endoscopically. Could save many patients surgeries for lymph node biopsies if proven.
Work by Yuma Wada et al
DDW ePoster Library; May 23 2021; 320503
Editorial:
MASLD formerly known as MAFLD, formerly known as NAFLD formerly known as NASH still known as fatty liver.
All good, since MASLD is indeed more precise.
#MASLD_is_more_precise
Liver disease gets new name and diagnostic criteria
Small study challenges notion of bacterial transfer for cure of c diff. In five patients, transfer of sterile filtrate of donor stool resolved symptoms.
New FMT pub of interest.
1. Fecal material filtered w 0.2um filter.
2. No cultivatable bacteria in filtrate in contrast to non-filtered material.
3. Microbiome + virome looks similar betwn the two.
4. Cdiff cured.
Related:
So we begin…at 12:30 our amazing post doc Said is presenting some serious data on small intestinal fungus detection on sequencing and symptoms. While less common than
#SIBO
it looks like 10^3 might be the cutoff there also. Candida is the bad actor.
Amazon discontinues
#VSL3
probiotic following findings of liability for false advertising- Visbiome high potency probiotic, containing original
#DesimoneFormulation
, now available.
“That’s how we retain stuff. Part of learning is the struggle. If you outsource learning to GPT, that struggle is gone.”
@ginakolata
story of training at Beth Israel succinctly reveals the promise of chatGPT, and some of its pitfalls in diagnosis.
1) Physicians need to retain
Somaya Ishaq, shown at her Irvine home, recently had her ovaries removed after genetic testing found a mutation that increased her cancer risk. Ishaq participates in a program for "previvors" at Hoag Hospital in Newport Beach.
I've seen several patients self test with both Promethease and 23andme. The hazard in acting on these results highlighted here, d/t false positives and negatives:
#LynchSyndrome
Offering financial incentives to both patients and their physicians to control LDL cholesterol appears to be cost-effective despite the added costs of the program, according to
@HarvardChanSPH
research